QVMS - ETF AI Analysis
Top Page
Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the past month, indicating positive recent momentum.
Strong-Performing Top Holdings
Several of the largest positions, such as Formfactor, Viavi Solutions, and ViaSat, have delivered strong year-to-date results that support the fund’s overall performance.
Low Expense Ratio
The fund’s relatively low fee means less of your return is eaten up by costs compared with many actively managed alternatives.
Negative Factors
Heavy U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification if the U.S. market struggles.
Small-Cap Volatility Risk
Because the fund focuses on smaller companies, its share price can be more sensitive to market swings and economic slowdowns.
Financials and Industrials Tilt
A large share of the portfolio is in financial and industrial stocks, which could hurt returns if these sectors face a downturn.
QVMS vs. SPDR S&P 500 ETF (SPY)
AUM252.58M
RegionNorth America
Expense Ratio0.15%
Beta0.93
IssuerInvesco
Inception DateJun 30, 2021
Dividend Yield1.15%
Asset ClassEquity
Index TrackedS&P SmallCap 600 Quality, Value & Momentum Top 90% Multi-Factor Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,424
30 Day Avg. Volume1,439
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
38.42Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering535
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QVMS Summary
The Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS) tracks the S&P SmallCap 600 Quality, Value & Momentum Top 90% Multi-Factor Index, focusing on smaller U.S. companies with potential for growth. It owns a wide mix of sectors like financials, industrials, and technology, and includes companies such as Eastman Chemical and LKQ. Investors might consider this ETF to diversify into small-cap stocks while using a rules-based approach that looks for quality, good value, and positive momentum. A key risk is that small-cap stocks can be more volatile and can go up and down more sharply than larger, more established companies.
How much will it cost me?The Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for actively managed funds, as it uses a multi-factor strategy to select investments while keeping costs relatively low.
What would affect this ETF?The QVMS ETF, focusing on U.S. small-cap stocks across sectors like financials, industrials, and technology, could benefit from economic growth and innovation in these industries, as well as favorable conditions for small-cap companies, such as lower interest rates or increased investor appetite for risk. However, it may face challenges from economic slowdowns, higher interest rates, or sector-specific issues like regulatory changes in healthcare or technology, which could impact its top holdings and overall performance.
QVMS Top 10 Holdings
QVMS is leaning into U.S. small caps with a noticeable tilt toward industrials and tech, and a few standout names are doing the heavy lifting. Powell Industries and Argan have been rising steadily on strong backlogs and solid earnings, giving the fund a sturdy industrial backbone. On the tech side, FormFactor and MaxLinear add momentum, though MaxLinear’s financial struggles make it a bit of a wild card. Healthcare exposure via BrightSpring and Krystal Biotech is climbing, but their rich valuations and leverage mean they can both power gains and inject volatility.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ViaSat | 0.92% | $2.33M | $11.34B | 426.05% | 56 Neutral | |
| Argan | 0.70% | $1.78M | $9.90B | 227.45% | 73 Outperform | |
| Element Solutions | 0.64% | $1.62M | $10.63B | 71.61% | 65 Neutral | |
| Molina Healthcare | 0.63% | $1.61M | $11.98B | -2.11% | 71 Outperform | |
| Maxlinear | 0.62% | $1.57M | $8.34B | 475.59% | 60 Neutral | |
| Formfactor | 0.61% | $1.55M | $9.63B | 196.15% | 68 Neutral | |
| Krystal Biotech | 0.59% | $1.49M | $11.06B | 157.16% | 80 Outperform | |
| BrightSpring Health Services, Inc. | 0.59% | $1.49M | $13.55B | 229.10% | 67 Neutral | |
| Alkermes | 0.54% | $1.37M | $9.10B | 87.95% | 80 Outperform | |
| JBT Marel | 0.54% | $1.36M | $7.59B | 13.47% | 73 Outperform |
QVMS Technical Analysis
Positive
―
Price Trends
32.84
Positive
31.40
Positive
29.88
Positive
Market Momentum
0.57
Positive
56.98
Neutral
45.75
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QVMS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 33.94, equal to the 50-day MA of 32.84, and equal to the 200-day MA of 29.88, indicating a bullish trend. The MACD of 0.57 indicates Positive momentum. The RSI at 56.98 is Neutral, neither overbought nor oversold. The STOCH value of 45.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QVMS.
QVMS Peer Comparison
Comparison Results
Performance Comparison
QVMS
Invesco S&P SmallCap 600 QVM Multi-factor ETF
34.22
8.23
31.67%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
EES
WisdomTree U.S. SmallCap Fund
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
SMDV
ProShares Russell 2000 Dividend Growers ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents